Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 450 publications
Robust CD4+ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma.
Journal: Science translational medicine
Published: July 29, 2026
Feasibility Study: Early Experiences With a Cancer Center's Virtual Expert Medical Opinion Program.
Journal: JCO oncology practice
Published: April 09, 2026
Impact of Bridging Response on Outcomes after CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: March 13, 2026
Eligibility versus appropriateness in allogeneic HCT.
Journal: Blood advances
Published: March 02, 2026
Lenalidomide-Related Diarrhea in Patients with Multiple Myeloma is Associated with Gut Microbiota Dysbiosis and Disruption of the Bile Acid Pool.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 23, 2026
A pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma.
Journal: Haematologica
Published: February 05, 2026
Low Dose Tocilizumab for Mitigation of Cytokine Release Syndrome With T-Cell Engaging Bispecific Antibodies.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 30, 2026
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 Alterations.
Journal: Transplantation and cellular therapy
Published: January 20, 2026
Daratumumab therapy for refractory immune cytopenias after allogeneic hematopoietic cell transplantation.
Journal: Bone marrow transplantation
Published: January 13, 2026
Last Updated: 09/26/2026